Home › Lupus › Texas › Houston
Lupus clinical trials in Houston, TX
14 studies for Lupus are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RecruitingPhase 3
- Research Site, Houston
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RecruitingPhase 2
- The University of Texas Health Science Center at Houston, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RecruitingPhase 3
- Novel Research LLC, Bellaire · 7 mi away
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
RecruitingPhase 3
- Prolato Clinical Research Center, Houston
- Accurate Clinical Research, Humble · 17 mi away
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · 7 mi away
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
RecruitingPhase 2
- Texas Children's Hospital, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
RecruitingPhase 1
- Baylor College of Medicine, Houston
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RecruitingPhase 1
- Accurate Clinical Research - Houston /ID# 278382, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RecruitingPhase 3
- Research Site, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
RecruitingPhase 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · 7 mi away
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Durham, NC12 studies
- Washington, DC11 studies
- Miami, FL10 studies
- Oklahoma City, OK9 studies
- San Diego, CA8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Philadelphia, PA8 studies
- Santa Monica, CA7 studies
- Plantation, FL7 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.